# Sandrine Montsma

> Sandrine Montsma is a Series A investor at Bridges Israel backing Wind Energy and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Bridges Israel](https://shizune.co/investors/profile/bridges-israel)
- Total investments: 2
- Last investment: Sep 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/sandrine-montsma-579690/

Sandrine Montsma is a Series A investor at Bridges Israel focused on Wind Energy and Biotechnology. Sandrine Montsma currently works as the Co-founder and Managing Partner for Bridges Israel. She Previously worked at Orbix Medical as the Vice Chairman and CEO. Sandrine Montsma attended the INSEAD.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Wind Energy | 1 | 50% |
| Biotechnology | 1 | 50% |
| Infrastructure | 1 | 50% |
| Sustainability | 1 | 50% |
| Building Material | 1 | 50% |

7 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ECOncrete | ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures, in the coastal and marine environment as well as other urban landscapes. The Company develops, produces and supports implementation of innovative concrete products designed for enhancing the biological and ecological value of coastal andmarine infrastructures. ECOncrete's unique biological traits encourage biogenic buildup. They also provide substantial structural and economic advantages in terms of increased stability and longevity, as well as a reduction in maintenance costs. | $5M | Series A | Sep 02, 2021 |  |
| ECOncrete | ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures, in the coastal and marine environment as well as other urban landscapes. The Company develops, produces and supports implementation of innovative concrete products designed for enhancing the biological and ecological value of coastal andmarine infrastructures. ECOncrete's unique biological traits encourage biogenic buildup. They also provide substantial structural and economic advantages in terms of increased stability and longevity, as well as a reduction in maintenance costs. | $5M | Series A | Jun 10, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Barclays](https://shizune.co/investors/profile/barclays-7c03) — VC Fund, 1 deal together
- [Barclays Corporate Banking](https://shizune.co/investors/profile/barclays-plc) — VC Fund, 1 deal together
- [Goldacre](https://shizune.co/investors/profile/goldacre) — VC Fund, 1 deal together

## About Bridges Israel

VC Fund · Agudat Israel, Israel

Bridges Israel is an impact investment fund which invests in Israeli businesses to generate competitive financial returns alongside significant measurable social Impact. Bridges Israel is an independent affiliate of Bridges Fund Management, a specialist fund manager focused exclusively on sustainable and impact investment, with offices in London,New York and San Francisco, more than 1 billion under management and a proven track record since 2002.

3 contacts available at Bridges Israel.

| Name | Title | Profile |
| --- | --- | --- |
| Ran Grodecki | Co-founder and Managing Partner | https://shizune.co/investors/profile/ran-grodecki |
| Sandrine Montsma | Co-founder and Managing Partner | https://shizune.co/investors/profile/sandrine-montsma |
| Gal Hayut | Managing Partner | https://shizune.co/investors/profile/gal-hayut |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sandrine Montsma invest in?

Sandrine Montsma invests primarily in Wind Energy, Biotechnology and Infrastructure startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sandrine Montsma last invest?

The most recent investment recorded for Sandrine Montsma closed in Sep 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co